Quidel Corporation
QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point of Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laborator… Read more
Quidel Corporation (QDEL) - Net Assets
Latest net assets as of December 2025: $1.92 Billion USD
Based on the latest financial reports, Quidel Corporation (QDEL) has net assets worth $1.92 Billion USD as of December 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($5.77 Billion) and total liabilities ($3.85 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $1.92 Billion |
| % of Total Assets | 33.29% |
| Annual Growth Rate | 12.73% |
| 5-Year Change | -0.46% |
| 10-Year Change | 857.23% |
| Growth Volatility | 49.73 |
Quidel Corporation - Net Assets Trend (1985–2025)
This chart illustrates how Quidel Corporation's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Quidel Corporation (1985–2025)
The table below shows the annual net assets of Quidel Corporation from 1985 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $1.92 Billion | -35.65% |
| 2024-12-31 | $2.98 Billion | -40.38% |
| 2023-12-31 | $5.01 Billion | +1.44% |
| 2022-12-31 | $4.93 Billion | +155.76% |
| 2021-12-31 | $1.93 Billion | +44.77% |
| 2020-12-31 | $1.33 Billion | +138.06% |
| 2019-12-31 | $559.82 Million | +31.54% |
| 2018-12-31 | $425.58 Million | +87.40% |
| 2017-12-31 | $227.10 Million | +13.20% |
| 2016-12-31 | $200.63 Million | -8.25% |
| 2015-12-31 | $218.68 Million | -10.75% |
| 2014-12-31 | $245.01 Million | +9.49% |
| 2013-12-31 | $223.78 Million | +12.01% |
| 2012-12-31 | $199.78 Million | +7.76% |
| 2011-12-31 | $185.39 Million | +64.76% |
| 2010-12-31 | $112.52 Million | -11.02% |
| 2009-12-31 | $126.45 Million | +6.05% |
| 2008-12-31 | $119.24 Million | +10.71% |
| 2007-12-31 | $107.70 Million | +4.29% |
| 2006-12-31 | $103.28 Million | +18.38% |
| 2005-12-31 | $87.24 Million | -3.26% |
| 2004-12-31 | $90.19 Million | +0.45% |
| 2003-12-31 | $89.78 Million | +43.06% |
| 2002-12-31 | $62.76 Million | +3.89% |
| 2001-12-31 | $60.41 Million | +3.61% |
| 2000-12-31 | $58.31 Million | +33.43% |
| 1999-12-31 | $43.70 Million | -2.24% |
| 1998-12-31 | $44.70 Million | +21.14% |
| 1997-12-31 | $36.90 Million | +4.83% |
| 1996-12-31 | $35.20 Million | +36.96% |
| 1995-12-31 | $25.70 Million | +7.53% |
| 1994-12-31 | $23.90 Million | +7.17% |
| 1993-12-31 | $22.30 Million | +104.59% |
| 1992-12-31 | $10.90 Million | +14.74% |
| 1991-12-31 | $9.50 Million | +33.80% |
| 1990-12-31 | $7.10 Million | +1875.00% |
| 1989-12-31 | $-400.00K | 0.00% |
| 1988-12-31 | $-400.00K | -121.05% |
| 1987-12-31 | $1.90 Million | -78.41% |
| 1986-12-31 | $8.80 Million | -44.65% |
| 1985-12-31 | $15.90 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Quidel Corporation's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 98510000000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | $2.92 Billion | 151.86% |
| Total Equity | $1.92 Billion | 100.00% |
Quidel Corporation Competitors by Market Cap
The table below lists competitors of Quidel Corporation ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Hoshizaki Corporation
PINK:HSHZY
|
$1.22 Billion |
|
STOKE THERAPEUT.DL-001
F:0GT
|
$1.22 Billion |
|
Thermax Limited
NSE:THERMAX
|
$1.22 Billion |
|
Toei Animation Co.Ltd
OTCGREY:TOEAF
|
$1.22 Billion |
|
KEYMED BIOSCIENCES -0001
F:64Z
|
$1.22 Billion |
|
Chongqing Iron & Steel Co Ltd Class A
SHG:601005
|
$1.22 Billion |
|
Bank of Maharashtra
NSE:MAHABANK
|
$1.22 Billion |
|
Sandy Spring Bancorp Inc
NASDAQ:SASR
|
$1.21 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Quidel Corporation's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 2,984,500,000 to 1,920,500,000, a change of -1,064,000,000 (-35.7%).
- Net loss of 1,131,800,000 reduced equity.
- New share issuances of 6,100,000 increased equity.
- Other comprehensive income increased equity by 36,200,000.
- Other factors increased equity by 25,500,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-1.13 Billion | -58.93% |
| Share Issuances | $6.10 Million | +0.32% |
| Other Comprehensive Income | $36.20 Million | +1.88% |
| Other Changes | $25.50 Million | +1.33% |
| Total Change | $- | -35.65% |
Book Value vs Market Value Analysis
This analysis compares Quidel Corporation's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.67x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 4.01x to 0.67x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1985-12-31 | $4.77 | $19.12 | x |
| 1986-12-31 | $2.51 | $19.12 | x |
| 1987-12-31 | $0.53 | $19.12 | x |
| 1988-12-31 | $-0.11 | $19.12 | x |
| 1989-12-31 | $-0.11 | $19.12 | x |
| 1990-12-31 | $0.58 | $19.12 | x |
| 1991-12-31 | $0.68 | $19.12 | x |
| 1992-12-31 | $0.62 | $19.12 | x |
| 1993-12-31 | $1.23 | $19.12 | x |
| 1994-12-31 | $1.22 | $19.12 | x |
| 1995-12-31 | $1.29 | $19.12 | x |
| 1996-12-31 | $1.54 | $19.12 | x |
| 1997-12-31 | $1.68 | $19.12 | x |
| 1998-12-31 | $1.86 | $19.12 | x |
| 2000-12-31 | $2.34 | $19.12 | x |
| 2001-12-31 | $2.06 | $19.12 | x |
| 2002-12-31 | $2.12 | $19.12 | x |
| 2003-12-31 | $2.96 | $19.12 | x |
| 2004-12-31 | $2.78 | $19.12 | x |
| 2005-12-31 | $2.68 | $19.12 | x |
| 2006-12-31 | $3.01 | $19.12 | x |
| 2007-12-31 | $3.26 | $19.12 | x |
| 2008-12-31 | $3.66 | $19.12 | x |
| 2009-12-31 | $4.16 | $19.12 | x |
| 2010-12-31 | $3.94 | $19.12 | x |
| 2011-12-31 | $5.56 | $19.12 | x |
| 2012-12-31 | $5.93 | $19.12 | x |
| 2013-12-31 | $6.40 | $19.12 | x |
| 2014-12-31 | $7.11 | $19.12 | x |
| 2015-12-31 | $6.41 | $19.12 | x |
| 2016-12-31 | $6.13 | $19.12 | x |
| 2017-12-31 | $6.73 | $19.12 | x |
| 2018-12-31 | $10.00 | $19.12 | x |
| 2019-12-31 | $12.99 | $19.12 | x |
| 2020-12-31 | $30.57 | $19.12 | x |
| 2021-12-31 | $45.00 | $19.12 | x |
| 2022-12-31 | $85.97 | $19.12 | x |
| 2023-12-31 | $74.94 | $19.12 | x |
| 2024-12-31 | $44.41 | $19.12 | x |
| 2025-12-31 | $28.33 | $19.12 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Quidel Corporation utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -58.93%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -41.45%
- • Asset Turnover: 0.47x
- • Equity Multiplier: 3.00x
- Recent ROE (-58.93%) is below the historical average (-11.63%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1985 | -0.63% | -1.05% | 0.54x | 1.10x | $-1.69 Million |
| 1986 | -92.05% | -108.00% | 0.52x | 1.63x | $-8.98 Million |
| 1987 | -384.21% | -119.67% | 1.07x | 3.00x | $-7.49 Million |
| 1988 | 0.00% | -35.63% | 1.50x | 0.00x | $-3.06 Million |
| 1989 | 0.00% | -13.33% | 1.50x | 0.00x | $-1.16 Million |
| 1990 | -77.46% | -19.78% | 1.23x | 3.18x | $-6.21 Million |
| 1991 | 8.42% | 3.02% | 1.39x | 2.01x | $-150.00K |
| 1992 | 6.42% | 2.53% | 1.31x | 1.94x | $-390.00K |
| 1993 | -8.97% | -7.04% | 0.86x | 1.48x | $-4.23 Million |
| 1994 | -17.15% | -13.18% | 0.90x | 1.44x | $-6.49 Million |
| 1995 | 2.33% | 1.74% | 1.04x | 1.30x | $-1.97 Million |
| 1996 | 9.94% | 8.35% | 0.99x | 1.20x | $-20.00K |
| 1997 | 2.98% | 2.41% | 0.96x | 1.30x | $-2.59 Million |
| 1998 | 17.23% | 16.31% | 0.90x | 1.18x | $3.23 Million |
| 2000 | -10.03% | -8.55% | 0.83x | 1.41x | $-11.68 Million |
| 2001 | 1.41% | 1.15% | 0.90x | 1.36x | $-5.19 Million |
| 2002 | 2.06% | 1.69% | 0.92x | 1.32x | $-4.98 Million |
| 2003 | 21.89% | 20.66% | 0.81x | 1.31x | $10.67 Million |
| 2004 | -6.97% | -7.99% | 0.70x | 1.25x | $-15.31 Million |
| 2005 | -10.61% | -10.03% | 0.81x | 1.30x | $-17.98 Million |
| 2006 | 21.03% | 20.49% | 0.83x | 1.23x | $11.39 Million |
| 2007 | 12.66% | 11.55% | 0.88x | 1.24x | $2.86 Million |
| 2008 | 15.81% | 14.71% | 0.90x | 1.20x | $6.92 Million |
| 2009 | 26.00% | 20.02% | 0.99x | 1.32x | $20.24 Million |
| 2010 | -10.02% | -9.94% | 0.53x | 1.91x | $-22.52 Million |
| 2011 | 4.12% | 4.81% | 0.57x | 1.50x | $-10.91 Million |
| 2012 | 2.50% | 3.21% | 0.64x | 1.21x | $-14.98 Million |
| 2013 | 3.30% | 4.21% | 0.65x | 1.21x | $-14.99 Million |
| 2014 | -2.89% | -3.87% | 0.41x | 1.83x | $-31.58 Million |
| 2015 | -2.78% | -3.10% | 0.48x | 1.86x | $-27.95 Million |
| 2016 | -6.88% | -7.21% | 0.49x | 1.94x | $-33.87 Million |
| 2017 | -3.60% | -2.94% | 0.30x | 4.12x | $-30.88 Million |
| 2018 | 17.43% | 14.20% | 0.65x | 1.89x | $31.62 Million |
| 2019 | 13.03% | 13.63% | 0.59x | 1.63x | $16.94 Million |
| 2020 | 60.80% | 48.76% | 0.89x | 1.40x | $677.02 Million |
| 2021 | 36.50% | 41.46% | 0.70x | 1.26x | $511.26 Million |
| 2022 | 11.12% | 16.80% | 0.37x | 1.79x | $55.24 Million |
| 2023 | -0.20% | -0.34% | 0.35x | 1.71x | $-510.69 Million |
| 2024 | -68.76% | -73.74% | 0.43x | 2.15x | $-2.35 Billion |
| 2025 | -58.93% | -41.45% | 0.47x | 3.00x | $-1.32 Billion |
Industry Comparison
This section compares Quidel Corporation's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $694,749,556
- Average return on equity (ROE) among peers: -25.46%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Quidel Corporation (QDEL) | $1.92 Billion | -0.63% | 2.00x | $1.22 Billion |
| Advanced Biomedical Technologies Inc (ABMT) | $-4.46 Million | 0.00% | 0.00x | $14.18K |
| Abbott Laboratories (ABT) | $4.82 Billion | 39.04% | 1.31x | $191.37 Billion |
| Acarix AB (publ) (ACIXF) | $1.93 Million | -127.02% | 0.21x | $26.42 Million |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $-72.62 Million | 0.00% | 0.00x | $4.05 Million |
| Adm Tronics Unltd (ADMT) | $-12.69K | 0.00% | 0.00x | $3.17 Million |
| Aethlon Medical Inc (AEMD) | $-3.07 Million | 0.00% | 0.00x | $2.79 Million |
| Acutus Medical Inc (AFIB) | $126.58 Million | -80.56% | 0.52x | $732.88K |
| Adapthealth Corp (AHCO) | $2.07 Billion | 7.56% | 1.54x | $914.25 Million |
| Allied Healthcare Products Inc. (AHPIQ) | $8.88 Million | -33.95% | 1.22x | $726.24 |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $3.39 Million | -59.65% | 0.38x | $9.18 Million |